Photobiomodulation energises the cellular repair process — activating fibroblasts, accelerating tissue regeneration, and supporting wound closure without drugs, side effects, or downtime.
*Free demos are only available for potential providers.
Chronic wounds affect millions of patients worldwide — from diabetic ulcers and pressure injuries to post-surgical sites and burns. When cellular energy is depleted, the healing process stalls.
MedWave integrates clinical-grade red light therapy (photobiomodulation) to energise the cells responsible for tissue repair — activating fibroblasts, promoting angiogenesis, and modulating inflammation to support faster, more complete wound closure.
Chronic wounds cost healthcare systems billions annually. Standard approaches — dressings, debridement, negative pressure therapy — address the wound environment but don’t directly energise the cellular repair machinery.
MedWave’s devices deliver clinical-grade red and near-infrared light that penetrates deep into tissue — stimulating fibroblast proliferation, promoting collagen synthesis, enhancing angiogenesis, and modulating the inflammatory cascade to support the body’s own healing process.
Zero consumables. Zero side effects. A device that transforms wound management outcomes backed by decades of peer-reviewed photobiomodulation research.
Traditional wound care focuses on the wound environment — moisture balance, infection control, pressure offloading — without directly addressing the depleted cellular energy that drives tissue repair.
Clinicians are increasingly recognising that chronic wounds stall because cells lack the energy to proliferate, migrate, and synthesise collagen. The repair cells need fuel — not just a clean wound bed.
MedWave bridges the divide. By delivering precise wavelengths of red light to mitochondria, we restore the ATP production that powers every stage of wound healing — from inflammation modulation to tissue remodelling.
Support accelerated wound closure, improved granulation tissue formation, enhanced collagen density, and better patient outcomes — all from a non-invasive device that complements your existing wound care protocols.
We bridge the gap between wound management and genuine tissue repair.
How precision red light therapy triggers a biological cascade that supports wound repair and tissue regeneration. Built on peer-reviewed photobiomodulation research.
Red light at 660nm directly energises fibroblasts — the cells responsible for producing collagen and rebuilding tissue. Studies show PBM enhances cell viability and proliferation, with irradiated fibroblasts migrating almost 3.5 times faster to close wounds compared to untreated cells. This acceleration is driven by increased basic fibroblast growth factor (bFGF) and activation of the Ras/MAPK signalling pathway.²
Chronic wounds are trapped in a prolonged inflammatory phase. PBM at 660nm down-regulates pro-inflammatory TNF-alpha while increasing VEGF and TGF-beta gene expression — shifting the wound from destructive inflammation toward constructive healing. In diabetic wound studies, 12 days of PBM treatment achieved up to 50% improvement in granulation tissue formation.¹
Wound healing requires oxygen and nutrient delivery through new blood vessel formation. PBM increases VEGF expression, promoting angiogenesis in the wound bed. Enhanced microcirculation brings oxygen, growth factors, and immune cells to the repair site while removing metabolic waste — creating the optimal environment for tissue regeneration.¹
Strong wound closure requires robust collagen architecture. PBM boosts ATP production in mitochondria, providing the cellular energy needed for collagen deposition and organisation. Systematic reviews confirm PBM improves collagen density and fibroblast proliferation, supporting stronger, more organised tissue repair that reduces the risk of wound recurrence.⁴
All clinical data sourced from peer-reviewed studies. Full references available below.
Most consumer red light panels scatter broad-spectrum light across the skin with minimal tissue penetration — far below the therapeutic thresholds established in wound healing research.
MedWave’s devices deliver precision red and near-infrared light wavelengths through 585 high-output LEDs at 3,000 watts total output — penetrating 3–4cm into tissue to reach the wound bed, surrounding vasculature, and underlying tissue structures where repair begins.
Structured treatment programmes designed to complement your existing wound care protocols.
A structured programme for chronic and non-healing wounds — diabetic ulcers, venous leg ulcers, and pressure injuries. Supports fibroblast activation, granulation tissue formation, and progressive wound closure.
Designed specifically for diabetic foot ulcers and diabetic wound complications. Targets the inflammatory pathway dysfunction common in diabetic healing to promote granulation tissue and reduce TNF-alpha expression.
For post-surgical wound healing, skin grafts, and acute tissue repair. Promotes faster wound closure, reduced inflammation, and improved scar quality through enhanced collagen organisation and cellular energy restoration.
Pairing MedWave devices with the Hypervibe whole body vibration plate creates a synergistic protocol: PBM activates fibroblasts and modulates inflammation while controlled vibration promotes circulation, lymphatic drainage, and oxygen delivery to healing tissue.
Research confirms whole body vibration increases oxygen consumption by approximately 22% and energy expenditure by approximately 20% — supporting the tissue repair process initiated by photobiomodulation.⁵
“Heal the tissue, not just the wound.”
Maximise Outcomes Per Treatment Room.
MedWave allows you to deploy a turnkey clinical asset that integrates seamlessly into your existing wound care workflow. The treatment complements your nursing staff and wound specialists — running alongside standard wound management protocols rather than competing for clinician time.
Unlike wound dressings, growth factors, and negative pressure supplies, MedWave requires no ongoing consumable costs. Once you own the asset, every treatment session is pure margin.
Wound care patients require structured courses of 12–20 sessions, with many transitioning to maintenance protocols — delivering predictable, recurring revenue over extended treatment periods.
Faster wound closure means fewer total dressing changes, fewer nursing hours per wound, and lower complication rates — improving clinical outcomes while reducing overall cost of care.
Real results from real practitioners and MedWave patients.
Pain Management & Sleep
Sleep Quality
Wound Recovery
General Wellbeing
Longevity & Wellness
Body Contouring
Sports Recovery
Eye Health
Wound Care & Pain Relief
Sports Performance & Recovery
Photobiomodulation for wound healing isn’t theory — it’s backed by decades of peer-reviewed clinical research. Select a category below to explore the studies for yourself.
Comprehensive review of 218 articles establishing PBM as a “potent, noninvasive photoceutical approach” for wound care. Wavelengths from 405–1,000nm and doses from 0.1–10 J/cm² provide therapeutic benefits across a broad range of chronic wounds. Highlights the need for standardised treatment parameters.
Read the study →Updated narrative review consolidating the evidence for PBM in wound healing across wound types. Confirms that PBM accelerates wound closure through fibroblast activation, collagen deposition, angiogenesis, and anti-inflammatory effects. Calls for standardised clinical protocols.
Read the study →Landmark review establishing PBM’s anti-inflammatory mechanisms relevant to wound healing: NF-kB modulation, M1-to-M2 macrophage phenotype shift, and reduced oxidative stress. Documents “almost complete lack of reported adverse effects.”
Read the study →PBM at 660nm down-regulated TNF-alpha in diabetic patients with pressure ulcers. Treatment for 12 days showed improvement of up to 50% in granulation tissue. Reduced TNF-alpha gene expression with increased VEGF and TGF-beta expression. Preclinical models showed positive wound healing effects in 94% of studies.
Read the study →Systematic review identifying optimal wavelengths in the 600nm and 800nm spectrum ranges for diabetic foot ulcer treatment. Studies demonstrate PBM accelerates healing through fibroblast proliferation and collagen deposition. Identifies the need for standardised treatment parameters.
Read the study →Evaluated LED therapy at 470nm (blue), 540nm (green), and 635nm (red) on wound healing in diabetic mice. Red and green light positively stimulated wound healing, while blue light was ineffective. Confirms wavelength selection is critical to clinical outcomes in diabetic wound care.
Read the study →Demonstrated that PBM accelerates burn wound healing through activation of endogenous latent TGF-β1. PBM-treated burns in mice showed improved healing with elevated TGF-β signalling and reduced inflammation-associated gene expression. Discrete effects observed on epithelium, fibroblasts, and macrophage functions.
Read the study →Systematic review of 38 preclinical studies. PBM favoured wound contraction (mean difference = −11.47, 95% CI −19.87 to −3.08). PBM also favoured angiogenesis at doses between 11–20 J/cm² and increased collagenisation rate. Moderate certainty of evidence.
Read the study →PBM at 660nm and 5 J/cm² enhanced cell viability and proliferation. Cell migration increased almost 3.5 fold within 24 hours post-irradiation. Improvement attributed to increased basic fibroblast growth factor (bFGF) and activation of the Ras/MAPK signalling pathway.
Read the study →Established a new burn wound model using the chorioallantoic membrane (CAM) assay and tested PBM’s effects on wound healing. Demonstrates that PBM promotes angiogenesis and vascular proliferation, supporting enhanced oxygen and nutrient delivery to healing tissue.
Read the study →PBM at 660nm led to higher mobilisation of Type-2 pericytes in photoactivated wounds compared to controls. Pericytes play a critical role in vascular stability and tissue regeneration, providing a novel mechanism by which PBM supports wound healing and skin repair.
Read the study →Wound care specialist Sr. René Black shares how she integrates MedWave into her treatment protocols for wound patients
Explore the science behind how photobiomodulation supports accelerated burn wound recovery
A practical look at the outcomes and experience of integrating MedWave into wound care practice
This presentation gives you a complete picture of the MedWave system, and how practices like yours are integrating photobiomodulation into patient care.
Schedule a Call With UsMedWave’s photobiomodulation technology extends far beyond wound care. Explore how red light therapy is transforming outcomes across multiple disciplines.
Non-invasive body contouring, skin rejuvenation, and measurable fat reduction powered by cellular energy.
Explore →Non-invasive relief for chronic pain, joint inflammation, and musculoskeletal conditions.
Explore →Support cognitive function, neuroprotection, and neurological recovery with transcranial PBM.
Explore →Build a high-margin wellness business with MedWave’s turnkey provider programme.
Explore →